MoonLake Immunotherapeutics Cash Flow Statement

Cash Flow Statement Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -64.51M-44.08M-121.24M
Depreciation and Depletion 0.01M0.01M
Share-based Compensation 9.65M7.11M7.28M
Gains from Investment Securities 0.44M3.64M0.55M
Cash from Operations -55.89M-42.78M-116.59M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.20M0.40M1.40M
Change in Working Capital
Change in Receivables 0.07M0.84M1.79M
Change in Account Payables -1.31M1.58M7.15M
Change in Accured Expenses 2.69M-0.33M5.17M
Other Working Capital Changes 2.73M6.35M12.89M
Investing Activities
Capital Expenditures 0.02M0.28M0.52M
Change in Acquisitions & Divestments 9.90M150.83M145.20M
Cash from Investing Activities -32.34M-25.18M-205.60M
Financing Activities
Cash from Financing Activities 119.69M479.70M51.31M
Additional items
Exchange Rate Effect 0.01M-0.08M0.13M
Change in Cash 31.47M411.66M-270.74M
Free Cash Flow -55.91M-43.06M-117.11M
Net Cash Flow 31.46M411.74M-270.87M